Hemostats Market By Product (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Collagen-Based Hemostats, Polysaccharide Hemostats), By Formulation (Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery), By End-User (Clinics, Hospitals, Ambulatory CentresCenters), And Region For 2024-2031
Report ID: 11749|No. of Pages: 202
Hemostats Market By Product (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Collagen-Based Hemostats, Polysaccharide Hemostats), By Formulation (Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery), By End-User (Clinics, Hospitals, Ambulatory CentresCenters), And Region For 2024-2031
Hemostats Market Valuation – 2024-2031
The advancements in surgical techniques, an increasing number of surgical procedures worldwide, and a rising prevalence of chronic diseases requiring surgical interventions. Thus, the technological advancements in surgical techniques surge the growth of market size surpassing USD 2.7 Billion in 2024 to reach the valuation of USD 4.25 Billion by 2031.
The ongoing innovations in hemostat materials and technologies, increasing healthcare expenditure in emerging economies, and a growing aging population require more surgical procedures. Thus, the ongoing innovations enable the market to grow at a CAGR of 5.81% from 2024 to 2031.
Hemostats Market: Definition/ Overview
Hemostats are medical devices or agents designed to control bleeding during surgical procedures or in cases of traumatic injury. These products work by promoting blood clotting (coagulation) or by mechanically sealing off blood vessels to stop blood flow. Hemostats play a crucial role in various medical fields, including general surgery, cardiovascular surgery, neurosurgery, and emergency medicine.
Furthermore, hemostats come in various forms, including mechanical devices like clips and staples, as well as absorbable and non-absorbable materials such as gelatin-based sponges, oxidized regenerated cellulose, and collagen-based products. Advanced hemostats may incorporate active biological components like thrombin or fibrin to enhance their effectiveness. The choice of hemostat depends on the specific surgical procedure, the type and severity of bleeding, and patient factors.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=11749
What are the Potential Impacts of Advanced Hemostatic Technologies on the Surgical Industry?
Advanced hemostatic technologies are poised to significantly impact the surgical industry by enhancing procedural efficiency and patient outcomes. These innovations, including nanoparticle-based hemostats and smart materials that respond to bleeding conditions, promise to reduce surgical time and minimize blood loss more effectively than traditional methods. By providing surgeons with more precise and rapid bleeding control, these technologies could enable more complex procedures to be performed with reduced risk, potentially expanding the range of treatable conditions and improving success rates in challenging surgeries.
Furthermore, advanced hemostats could lead to shorter recovery times and reduced complications for patients, potentially decreasing hospital stays and healthcare costs. The integration of these technologies with minimally invasive and robotic surgical systems may also drive a shift towards less invasive procedures, benefiting patients through smaller incisions and faster healing. As these advanced hemostats become more widely adopted, they could reshape surgical protocols and training, necessitating new skills for healthcare professionals and potentially altering the landscape of surgical specialties.
How Will Changes in Healthcare Policies Affect the Adoption of Hemostatic Products?
Changes in healthcare policies are likely to have a significant impact on the adoption of hemostatic products. As healthcare systems worldwide increasingly focus on cost-effectiveness and patient outcomes, policies that promote value-based care may accelerate the adoption of advanced hemostats. These products, while potentially more expensive upfront, can reduce overall healthcare costs by decreasing surgical complications, shortening hospital stays, and improving patient recovery times. Policies that incentivize hospitals and surgeons to improve efficiency and reduce readmission rates may drive increased use of effective hemostatic solutions.
Furthermore, regulatory changes aimed at enhancing patient safety and reducing adverse events during surgeries could boost the adoption of newer, more effective hemostatic products. Policies that streamline the approval process for innovative medical devices, particularly those addressing critical needs in surgical care, may lead to faster market entry for advanced hemostats. Additionally, healthcare reforms that expand access to surgical procedures in developing countries could significantly increase the global demand for hemostatic products, as these nations seek to improve their surgical capabilities and outcomes.
Category-Wise Acumens
How does the Increasing Prevalence of Cardiovascular Diseases Surge the Growth of the Cardiovascular Surgery Segment?
The cardiovascular surgery segment dominates the hemostats market. Cardiovascular procedures, such as coronary artery bypass grafting and heart valve replacements, often involve complex manipulations of highly vascularized tissues, making effective bleeding control crucial. The increasing prevalence of cardiovascular diseases globally, coupled with advancements in cardiac surgical techniques, has led to a rise in the number of these procedures. This trend has created a substantial and growing demand for specialized hemostatic products that can address the unique challenges of cardiac surgeries, such as the need for rapid and durable hemostasis in a dynamic, high-pressure environment.
Furthermore, the critical nature of cardiovascular surgeries means that surgeons often prefer advanced hemostatic solutions that offer superior efficacy and reliability. This preference is driving innovation in the hemostat market, with manufacturers developing products specifically tailored for cardiovascular applications. These may include products with enhanced adhesive properties to withstand blood pressure or those that can be applied in minimally invasive cardiac procedures. As cardiovascular surgeries continue to evolve, becoming less invasive and more complex, the demand for sophisticated hemostats is expected to grow, further propelling the overall market expansion and shaping product development strategies in the industry.
How does the Increasing Frequency of Emergency Surgeries in Hospital Settings Surge the Growth of the Hospital Segment?
The hospital segment dominates the hemostats market driven by the increasing frequency of emergency surgeries in hospital settings, which is significantly boosting the hemostats market. As trauma cases, acute medical conditions, and unforeseen complications rise, hospitals face a growing need for rapid and effective bleeding control solutions. Emergency surgeries often involve critical situations where time is of the essence, and conventional hemostatic methods may be insufficient. This urgent demand drives the adoption of advanced hemostatic products that can quickly and reliably stop bleeding, even in challenging conditions. Consequently, hospitals invest in a diverse range of hemostats to ensure they are well-equipped to handle various emergencies.
Furthermore, the unpredictable nature of emergency surgeries necessitates that hospitals maintain a robust inventory of hemostatic products. This requirement leads to consistent and potentially increasing orders from hospital systems, providing a steady growth driver for the hemostats market. The emphasis on improving emergency care outcomes also encourages the development and adoption of innovative hemostatic technologies specifically designed for rapid deployment in high-pressure situations. As hospitals strive to enhance their emergency surgical capabilities, the demand for versatile, easy-to-use, and highly effective hemostats continues to grow, further stimulating market expansion and product innovation in the hemostats sector.
Gain Access to Hemostats Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=11749
Country/Region-wise Acumens
What Role Do Regulatory Frameworks in North America Play in Shaping the Development of Hemostatic Products?
North America substantially dominates the hemostats market owing to the regulatory frameworks in North America, particularly those established by the U.S. Food and Drug Administration (FDA) and Health Canada, which play a crucial role in shaping the development of hemostatic products. These agencies set stringent standards for safety, efficacy, and quality, which directly influence product design, testing protocols, and manufacturing processes.
The FDA’s premarket approval (PMA) process for Class III medical devices, which includes many advanced hemostatic products, requires extensive clinical trials and data submission. This rigorous approach drives manufacturers to invest heavily in research and development, leading to innovative products with demonstrated safety and effectiveness. Additionally, post-market surveillance requirements encourage ongoing refinement and improvement of hemostatic technologies, ensuring their continued safety and efficacy in real-world clinical settings. These regulatory frameworks ultimately foster a culture of continuous innovation while maintaining high standards for patient safety.
What Role Does the Expanding Medical Tourism Sector in Asia Pacific Play in Boosting the Demand for Hemostats?
Asia Pacific is anticipated to witness the fastest growth in the hemostats market during the forecast period owing to the growth of medical tourism has led to an increase in complex surgical procedures being performed in the region. Countries like Thailand, Singapore, and India have become popular destinations for a wide range of surgeries, from cosmetic procedures to organ transplants. This surge in surgical activity naturally drives up the demand for hemostatic products, which are essential for managing bleeding during and after operations. As these countries strive to offer world-class medical services, they are investing in advanced hemostatic technologies to ensure optimal patient outcomes and maintain their competitive edge in the global medical tourism market.
Furthermore, the medical tourism sector’s emphasis on quality and patient safety has raised standards across the healthcare industry in Asia Pacific. To attract international patients, hospitals and clinics are adopting the latest medical technologies, including advanced hemostatic products. This trend is not limited to premier hospitals catering to medical tourists but is also influencing local healthcare providers who are upgrading their facilities and practices to compete. Consequently, the demand for high-quality hemostats is increasing across the broader healthcare landscape, driven by the ripple effect of medical tourism’s quality standards.
Competitive Landscape
The Hemostats Market is exceptionally competitive, driven by product innovation, different formulations, and rising surgical demand. To increase market share, key players prioritize technical developments and global expansion.
Some of the prominent players operating in the hemostats market include:
- CR Bard, Inc.
- Braun Melsungen AG
- Baxter International, Inc.
- Integra LifeSciences
- Marine Polymer Technologies, Inc.
- Teleflex
- Ethicon, Inc.
- Pfizer, Inc.
- Z-Medica LLC
- Gelita Medical GmbH
- Anika Therapeutics, Inc.
- Stryker
Latest Developments
- In March 2024, Baxter International announced the launch of an advanced fibrin sealant Baxter introduced a next-generation fibrin sealant with improved adhesive properties and faster clotting time.
- In January 2024, Ethicon (Johnson & Johnson) expanded its hemostatic powder portfolio Ethicon received FDA approval for a new formulation of its hemostatic powder, designed for minimally invasive surgeries.
- In November 2023, Integra LifeSciences announced the acquisition of regenerative medicine startup Integra LifeSciences acquired a biotech company specializing in plant-based hemostatic agents.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~5.81% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | CR Bard, Inc., Braun Melsungen AG, Baxter International Inc., Integra LifeSciences, Marine Polymer Technologies Inc., Teleflex, Ethicon Inc., Pfizer Inc., Z-Medica LLC, Gelita Medical GmbH, Anika Therapeutics Inc., Stryker. |
| Customization | Report customization along with purchase available upon request |
Hemostats Market, By Category
Product:
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose-Based Hemostats
- Collagen-Based Hemostats
- Polysaccharide Hemostats
Formulation:
- Matrix & Gel Hemostats
- Sheet & Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
End-User:
- Clinics
- Hospitals
- Ambulatory Centers
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL HEMOSTATS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HEMOSTATS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.3 Drivers
4.4 Restraints
4.5 Opportunities
4.6 Porters Five Force Model
4.7 Value Chain Analysis
5 GLOBAL HEMOSTATS MARKET, BY END USER
5.1 Overview
5.2 Clinics
5.3 Hospitals
5.4 Ambulatory Centers
6 GLOBAL HEMOSTATS MARKET, BY PRODUCT
6.1 Overview
6.2 Thrombin-Based Hemostats
6.3 Oxidized Regenerated Cellulose-Based Hemostats
6.4 Collagen-Based Hemostats
6.5 Polysaccharide Hemostats
7 GLOBAL HEMOSTATS MARKET, BY FORMULATION
7.1 Overview
7.2 Matrix & Gel Hemostats
7.3 Sheet & Pad Hemostats
7.4 Powder Hemostats
7.5 Sponge Hemostats
8 GLOBAL HEMOSTATS MARKET, BY APPLICATION
8.1 Overview
8.2 Orthopedic Surgery
8.3 General Surgery
8.4 Neurological Surgery
8.5 Cardiovascular Surgery
8.6 Gynecological Surgery
9 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.2 Middle East and Africa
10 GLOBAL HEMOSTATS MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies
11 COMPANY PROFILES
11.1 CR Bard, Inc
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 B. Braun Melsungen AG
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Baxter International, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Integra LifeSciences
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Marine Polymer Technologies, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Teleflex
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Ethicon, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Pfizer, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Z-Medica LLC
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Gelita Medical GmbH
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
